Westwood Holdings Group Inc. Has $41.52 Million Stock Holdings in Avanos Medical, Inc. (NYSE:AVNS)

Westwood Holdings Group Inc. decreased its position in shares of Avanos Medical, Inc. (NYSE:AVNS) by 1.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,084,117 shares of the company’s stock after selling 30,415 shares during the period. Westwood Holdings Group Inc. owned about 4.54% of Avanos Medical worth $41,516,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in the company. Canada Pension Plan Investment Board acquired a new stake in Avanos Medical in the second quarter valued at approximately $70,000. EntryPoint Capital LLC raised its stake in shares of Avanos Medical by 97.6% during the first quarter. EntryPoint Capital LLC now owns 5,601 shares of the company’s stock valued at $112,000 after acquiring an additional 2,766 shares during the last quarter. XTX Topco Ltd bought a new position in shares of Avanos Medical during the second quarter valued at $202,000. Janney Montgomery Scott LLC raised its stake in shares of Avanos Medical by 19.1% during the first quarter. Janney Montgomery Scott LLC now owns 13,010 shares of the company’s stock valued at $259,000 after acquiring an additional 2,082 shares during the last quarter. Finally, Quest Partners LLC bought a new position in shares of Avanos Medical during the fourth quarter valued at $327,000. Institutional investors and hedge funds own 95.17% of the company’s stock.

Avanos Medical Price Performance

AVNS stock opened at $24.14 on Friday. The company has a fifty day moving average price of $23.32 and a 200-day moving average price of $20.85. The company has a market capitalization of $1.11 billion, a P/E ratio of -18.15 and a beta of 0.91. Avanos Medical, Inc. has a 52-week low of $17.24 and a 52-week high of $25.36. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.49 and a current ratio of 2.28.

Avanos Medical (NYSE:AVNS) last released its quarterly earnings results on Wednesday, July 31st. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.05. The firm had revenue of $171.70 million during the quarter, compared to the consensus estimate of $170.67 million. Avanos Medical had a net margin of 1.13% and a return on equity of 4.48%. The company’s revenue for the quarter was up 1.4% on a year-over-year basis. During the same quarter last year, the firm earned $0.24 earnings per share. As a group, equities analysts expect that Avanos Medical, Inc. will post 1.39 EPS for the current year.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.